EUDA logo

EUDA Health Holdings
EUDA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$85.83M
EV
$87.92M
Shares Outstanding
37.16M
Beta
-0.13
Industry
Medical - Healthcare Information Services

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
1
P/E 2025E
115.50x
P/Revenue 2025E
9.20x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
22.00%
Net Profit Margin 2025E
9.24%
ROE 2025E
-
ROCE 2024
-

Dividends

DPS 2025E
-
Payout Ratio 2025E
-
Div. Yield 2025E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About EUDA Health Holdings Limited

gainify
EUDA logo

EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provide...

Sector

Healthcare

Industry

Medical - Healthcare Information Services

CEO

Lim, Alfred

Employees

117

IPO Date

2021-12-14

Headquarters

60 Kaki Bukit Place, No. 03-01 Eunos Techpark, Singapore 415979, Singapore

📊 Stock Price & Performance

The last closing price of EUDA Health Holdings (EUDA) is $2.39, reflecting a +2.14% change from the prior session. Last updated: December 31, 2025 at 4:03 PM Eastern Time

Review the recent EUDA stock performance trends:Past 1 Month: EUDA Health Holdings (EUDA) shares have -25.96%.Past 3 Months: The stock has +32.76%.Past 6 Months: EUDA shares have -35.47%. Last updated: December 31, 2025 at 11:31 PM Eastern Time

Over the last year, EUDA Health Holdings (EUDA) has established a 52-week price range between a high of $4.70 and a low of $1.03. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:31 PM Eastern Time

EUDA Health Holdings (EUDA) is considered a low volatility stock. It has a beta of -0.13, which means it typically moves in the opposite direction of the broader market, with a magnitude of approximately 0.13 times the market's movement. Over the past 52 weeks, EUDA has traded within a $1.03 – $4.70 range. Last updated: December 31, 2025 at 11:31 PM Eastern Time

Based on current EUDA analyst forecasts and market assumptions, the consensus price target for EUDA Health Holdings (EUDA) is $6.00 for 2027. Relative to the current price of $2.39, this implies a positive upside of +159.74%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: December 31, 2025 at 11:31 PM Eastern Time

💰 Financial Metrics & Reports

The current EUDA Health Holdings (EUDA) market capitalization is approximately $85.83M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, EUDA Health Holdings's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:31 PM Eastern Time

In the most recently reported quarter, EUDA Health Holdings (EUDA) generated $1.53M in revenue, representing a +60.23% year over year change. For the next quarter, analyst consensus currently expects revenue of approximately $3.82M, implying an expected +263.30% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: December 31, 2025 at 7:19 PM Eastern Time

In the most recently reported fiscal year, EUDA Health Holdings (EUDA) generated net income of $-15.36M, compared with $-10.04M in the prior fiscal year, representing a -52.97% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of $862.00K. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: December 31, 2025 at 7:19 PM Eastern Time

According to its latest quarterly filing, EUDA Health Holdings (EUDA) reported EBITDA of $-0.52M, representing a +34.18% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: December 31, 2025 at 7:19 PM Eastern Time

Based on the latest available data, EUDA Health Holdings (EUDA) is currently trading at a last twelve months (LTM) P/E ratio of 304.85x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: December 31, 2025 at 7:19 PM Eastern Time

📅 Earnings & Dividends

In the most recently reported quarter, EUDA Health Holdings (EUDA) revenue was $1.53M, compared with analyst consensus expectations of $3.41M, representing a -55.17% revenue surprise versus expectations. Earnings per share (EPS) for the quarter were $-0.02, compared with consensus estimates of $-0.02, resulting in an +19.00% EPS surprise. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: December 31, 2025 at 7:19 PM Eastern Time

EUDA Health Holdings's (EUDA) earnings reports, including quarterly and annual financial statements, are available through the company's official regulatory filings with the U.S. Securities and Exchange Commission (SEC). On Gainify, you can access EUDA Health Holdings's full set of filings, including earnings releases, Form 10-Q, Form 10-K, and other disclosures, in one place: EUDA Health Holdings SEC Filings These filings provide detailed information on EUDA Health Holdings's financial performance and are considered the primary source of verified financial data for publicly traded companies.

EUDA Health Holdings (EUDA) does not currently pay a dividend. Over the last twelve months (LTM), the company paid $0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: December 31, 2025 at 7:19 PM Eastern Time

📈 Analyst Information

Analyst assessments of whether EUDA Health Holdings (EUDA) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: $2.39Consensus price target: $6.00Implied return: +159.74% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: December 31, 2025 at 7:19 PM Eastern Time

Based on the latest available analyst coverage, EUDA Health Holdings (EUDA) currently carries a Buy consensus rating. Analysts' average EUDA price target is $6.00. Relative to the current share price of $2.39, this suggests a potential price change of approximately +159.74%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: December 31, 2025 at 7:19 PM Eastern Time

Like other publicly traded stocks, EUDA Health Holdings (EUDA) shares are bought and sold on stock exchanges such as Nasdaq and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for EUDA Health Holdings (EUDA) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add EUDA to your watchlist.

EUDA Health Holdings trades under the ticker symbol EUDA on the Nasdaq stock exchange. The ticker EUDA is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, EUDA Health Holdings (EUDA) employs approximately 117 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: December 31, 2025 at 11:31 PM Eastern Time

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.